{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:04:00Z","timestamp":1761897840260,"version":"3.40.5"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>The role of IFN\u03b1 in chronic myeloid leukaemia patients who have achieved a deep molecular response (DMR) is still unknown. The study reported by Irani et al., which shows the prospective biological effects of the drug in combination with a second\u2010generation tyrosine kinase inhibitor, pave the way for further clinical studies aimed at increasing the rate of DMR for a possible successful discontinuation.<\/jats:p><jats:p>Commentary on: Irani et al. Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon\u2010alpha. Br J Haematol 2023;202:1127\u20131136.<\/jats:p>","DOI":"10.1111\/bjh.19013","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T05:20:31Z","timestamp":1691126431000},"page":"1087-1088","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interferon in chronic myeloid leukaemia: Is it useful for treatment\u2010free remission?"],"prefix":"10.1111","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-6162","authenticated-orcid":false,"given":"Massimo","family":"Breccia","sequence":"first","affiliation":[{"name":"Hematology, Department of Translational and Precision Medicine Sapienza University  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-3514","authenticated-orcid":false,"given":"Giuseppe","family":"Saglio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences University of Turin  Turin Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0047"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.313"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07815"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.214"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146412"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18486"},{"issue":"3","key":"e_1_2_2_9_1","first-page":"S157","article-title":"Nilotinib vs nilotinib+peg\u2010interferon alpha induction and nilotinib or peg\u2010interferon alpha maintenance therapy for newly diagnosed chronic myeloid leukemia patients. The Tiger trial","volume":"7","author":"Hochhaus A","year":"2023","journal-title":"HemaSphere"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-169324"},{"key":"e_1_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/79526"},{"key":"e_1_2_2_12_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/bjh.18984","article-title":"Immune modulation in chronic myeloid leukemia patients treated with nilotinib and interferon\u2010alpha","volume":"202","author":"Irani YD","journal-title":"Br J Haematol"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195594"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:37:47Z","timestamp":1694425067000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1111\/bjh.19013"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19013","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"2023-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}